Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
This was 3 months ago
LocationHybrid event
The European Health Forum Gastein (EHFG) is a European health policy platform, which aims to provide an inclusive platform for discussions and advancement of health, solidarity and equity in the EU and beyond.
Every year, EHFG’s annual conference brings together leading experts, decision-makers and members of the European public health community. The conference theme of the 2024 edition is 'Shifting sands of health - Democracy, demographics, digitalisation'. Among the speakers are officials from the Commission, European Medicines Agency & WHO.
Please note that this is a paying event for participation on-site. Online participation is offered free of charge.
More information, the detailed programme and registration on the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space AI, data & cloud Deployment: Best use of technologies
Security AI, data & cloud Cybersecurity Defence Space
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.